Topical Cannabidiol for the Treatment of Chemotherapy-Induced Peripheral Neuropathy
Status:
Not yet recruiting
Trial end date:
2024-04-01
Target enrollment:
Participant gender:
Summary
This clinical trial compares topical cannabidiol to placebo in improving chemotherapy-induced
peripheral neuropathy, or painful sensations in your hands or feet due to chemotherapy.
Peripheral neuropathy is a nerve problem that causes pain, numbness, tingling, swelling, or
muscle weakness in different parts of the body. It usually begins in the hands or feet and
gets worse over time. Peripheral neuropathy caused by chemotherapy is called
chemotherapy-induced peripheral neuropathy (CIPN). CIPN is commonly seen in patients
receiving certain chemotherapy medications and is hard to treat. Medications commonly used to
treat CIPN have limited benefits and may cause significant side effects. A small report
showed that topical cannabidiol may help treat neuropathy in patients with diabetes. This
study is being done to determine if cannabidiol cream can help improve the symptoms of CIPN.